Fry’s Path Capital

Fry’s Path Capital provides comprehensive investment advisory services.
https://crunchbase.com/organization/***
https://linkedin.com/company/***

Dwight Keysor

Co-Founder and Managing Partner

4 past transactions

SafeRide Health

Series C in 2023
SafeRide Health is a healthcare technology company specializing in non-emergency medical transportation. Its platform leverages AI and data analytics to enhance patient experience, improve population health, and optimize fleet management for healthcare providers.

Luminoah

Series A in 2023
Luminoah is a medical device company that develops a closed-loop, personalized enteral nutrition platform. This platform aims to enhance chronic disease care by offering a compact wearable pump, smart nutrition consumables, a patient-facing mobile app, and a provider intelligence platform. These tools enable real-time monitoring of patients' progress and improve adherence across both home and clinical environments.

Vitara Biomedical

Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

SafeRide Health

Series B in 2021
SafeRide Health is a healthcare technology company specializing in non-emergency medical transportation. Its platform leverages AI and data analytics to enhance patient experience, improve population health, and optimize fleet management for healthcare providers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.